NURS 6630 DQ Therapy for Clients With Comorbid Conditions
NURS 6630 DQ Therapy for Clients With Comorbid Conditions
As a psychiatric mental health nurse practitioner, you will frequently work with clients
who have comorbid conditions. For instance, you may treat a 19-year-old male with
Down syndrome and increasing violent behaviors; a middle-aged female with
schizophrenia, diabetes, and poor renal function; or an older adult with a mental
disorder, stage I Alzheimer’s disease, and chronic obstructive pulmonary disease
(COPD). In cases like these, you must draw from foundational knowledge of
pathophysiology and collaborate with other healthcare providers to ensure optimal
safely and efficacy of psychopharmacological therapies for clients.
This week, as you study therapy for patients with comorbid conditions, you examine
psychopharmacologic approaches to treatment for clients across the lifespan.
Final Exam
This exam will cover the following topics, which relate to psychopharmacologic
approaches to treatment for clients across the lifespan:
Therapy for Clients with Pain and Sleep/Wake Disorders
Therapy for Clients with Impulsivity, Compulsivity, and Addiction
Therapy for Clients with ADHD
Therapy for Clients with Dementia
Therapy for Clients with Comorbid Conditions
Learning Objectives
Students will:
Assess psychopharmacologic approaches to treatment for clients across the lifespan
Learning Resources
Note: To access this week’s required library resources, please click on the link to the
Course Readings List, found in the Course Materials section of your Syllabus.
Required Readings
Note: All Stahl resources can be accessed through this link provided.
Stahl, S. M. (2014a). Stahl’s illustrated violence: Neural circuits, genetics and treatment.
New York, NY: Cambridge University Press.
To access the following chapter, click on the Illustrated Guides tab and then the
Violence tab.
Chapter 3, “Treatment of Violence and Aggression”
Stahl, S. M. (2014b). The prescriber’s guide (5th ed.). New York, NY: Cambridge
University Press.
To access information on the following medications, click on The Prescriber’s Guide,
5th ed tab on the Stahl Online website and select the appropriate medication.
Review the following medications:
For Alzheimer’s disease
donepezil
galantamine
memantine
rivastigmine
For Parkinson’s disease with dementia
rivastigmine
Crocker, A. G., Prokić, A., Morin, D., & Reyes, A. (2014). Intellectual disability and co-
occurring mental health and physical disorders in aggressive behaviour. Journal of
Intellectual Disability Research, 58(11), 1032-1044. doi:10.1111/jir.12080
Erickson, S. C., Le, L., Zakharyan, A., Stockl, K. M., Harada, A. M., Borson, S., & …
Curtis, B. (2012). New-onset treatment-dependent diabetes mellitus and hyperlipidemia
associated with atypical antipsychotic use in older adults without schizophrenia or
bipolar disorder. Journal of the American Geriatrics Society, 60(3), 474–479.
doi:10.1111/j.1532-5415.2011.03842.x
Hulvershorn, L. A., Schroeder, K. M., Wink, L. K., Erickson, C. A., & McDougle, C. J.
(2015). Psychopharmacologic treatment of children prenatally exposed to drugs of
abuse. Human Psychopharmacology, 30(3), 164-172. doi:10.1002/hup.2467
Malhotra, A. K., Zhang, J., & Lencz, T. (2012). Pharmacogenetics in psychiatry:
Translating research into clinical practice. Molecular Psychiatry, 17(8), 760-769.
doi:10.1038/mp.2011.146
Substance Abuse and Mental Health Services Administration. (2013). Substance abuse
treatment for persons with co-occurring disorders: A treatment improvement protocol
TIP 42. Retrieved from https://store.samhsa.gov/system/files/sma13-3992.pdf
Document: Final Exam Study Guide (PDF)
Optional Resources
Stahl, S. M. (2014a). Stahl’s illustrated violence: Neural circuits, genetics and treatment.
New York, NY: Cambridge University Press.
To access the following chapters, click on the Illustrated Guides tab and then the
Violence tab.
Chapter 1, “Which Individuals Will Become Violent or Aggressive?”
Chapter 2, “Neurobiology and Genetics of Violence and Aggression”
Final Exam:
This exam will cover the following topics, which relate to psychopharmacologic
approaches to treatment for clients across the lifespan:
Therapy for Clients with Pain and Sleep/Wake Disorders
Therapy for Clients with Impulsivity, Compulsivity, and Addiction
Therapy for Clients with ADHD
Therapy for Clients with Dementia
Therapy for Clients with Comorbid Conditions
By Day 7
Complete the Final Exam. Prior to starting the exam, you should review all of your
materials. There is a 2-hour time limit to complete this 76-question exam. You may only
attempt this exam once.
This exam is a test of your knowledge in preparation for your certification exam. No
outside resources including books, notes, websites, or any other type of resource are
to be used to complete this exam. You are expected to comply with Walden
University’s Code of Conduct.
Submit Your Final Exam by Day 7
To submit your Final Exam:
Week 11 Final Exam
Congratulations! After you have finished all of the assignments for this week, you have
completed the course. Please submit your Course Evaluation by Day